Navi Mumbai, India (PressExposure) March 17, 2009 -- A new report the business intelligence specialists, finds that an increasing number of individuals are opting for minimally invasive surgeries and treatment options. Stents, heart valves, and cardiac resynchronization therapy will be the key segments driving growth in the global cardiovascular devices market. report, âThe Future of the Cardiovascular Devices Market to 2012â, highlights this development as one of the key factor driving growth of the market.
New Product Releases and Favorable Trial Results Breathe New Life in the Stents Market
The global Drug Eluting Stents (DES) market valued at $5.75 billion in 2007 is expected to grow by 7.2% during 2007-2012 to reach $8.15 billion by 2012. Positive clinical outcomes from Abbott Vascularâs XIENCEâ¢ V Everolimus Eluting Coronary Stent and Medtronicâs EndeavorÂ® Zotarolimus-Eluting Coronary Stent and the subsequent US launch that followed helped stabilize the DES market in 2008.
Very few medical equipment sectors were as dynamic as the DES market during the past few years. More than 80% growth in 2004, a decline of 17.1% in 2007, a monopolistic market for most of its first year of launch in 2003 and a fiercely competitive market now â the DES sector has seen it all. Even as the market was grappling with concerns over late stage thrombosis following the use of DES in 2005-06, the results of COURAGE trial in March, 2007 worsened the situation and stent sales slipped down to a record level. Leading players in this sector showed revenue erosion to the tune of 20-30%. The market which showed the first sign of a revival in early 2008, recorded a positive yearly growth over 2007.
Cardiac Resynchronization Therapy to Bolster Growth in the Cardiac Rhythm Management Market
The Cardiac Resynchronization Therapy (CRT) devices market valued at $3.9 billion in 2007 is forecast to grow by 17.6% annually to reach $8.76 billion by 2012, accounting for 54.7% of the Cardiac Rhythm Management (CRM) market value. The CRM market valued at $9.05 billion in 2007 is expected to grow by 12.1% annually during 2007-2012 to reach $16.02 billion by 2012.
The increase in the use of CRT will be aided by high disease incidence. For instance, more than 22 million people worldwide suffer from congestive heart failure (CHF), a potentially debilitating disease. With more than half a million new CHF cases being detected every year in the US alone, the market is slated to continue its growth trajectory.
Percutaneous Procedures to Drive Growth in the Heart Valves Market
Driven by an increase in acceptance and penetration of percutaneous procedures, the global heart valves market, valued at $1.22 billion in 2007 is expected to grow by 5.4% annually during 2007-2012 to reach $1.59 billion by 2012.
The shift from traditional implantation of valves to the new technology of transcatheter valves is one of the key events that substantiate this trend. The time saving, less painful and minimally invasive characteristics associated with this procedure will continue to bolster the penetration of transcateter valves.
Industry Consolidations Will Continue To Reshape the Cardiovascular Devices Competitive Landscape
The global cardiovascular devices market is set to see heightened consolidation activity, driven primarily by Mergers & Acquisitions (M&As) in the interventional cardiology, cardiovascular surgery, and peripheral vascular devices market segments. In 2007, a total of 134 M&A deals were signed in the cardiovascular devices market, with interventional cardiology, cardiovascular surgery, and peripheral vascular devices categories together accounting for 52% of the deal volume, according to medical equipment deals database. The recent devaluation in market worth of small and mid-cap companies in the cardiovascular device sector in light of the financial crisis is expected to trigger fresh bouts of consolidation in the next 3-5 year period.
For vast range of market reports you can visit: [http://www.bharatbook.com/Market-Research/Medical-Equipment.html] Or Contact us at: